ChinaCureLink3 days ago11 min readBlogMultiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS
ChinaCureLink4 days ago11 min readBlogIs China Effective at Treating Leukemia? Domestic CAR-T Reaches Up to 92% Response in Refractory B-ALL
ChinaCureLink4 days ago10 min readBlog2026 Breakthrough: China's CAR-T for Advanced Lymphoma Reaches 79%+ Response Rate
ChinaCureLinkJun 198 min readCasesNine Years, One Leap: How Multiple Myeloma Led an Italian Woman to CAR-T Therapy in China
ChinaCureLinkJun 187 min readCasesRefractory AML, One Last Option: How a Bone Marrow Transplant in China Brought a Young Husband Back to Life
ChinaCureLinkMay 2611 min readBlogMedical Tourism from New Zealand to China: Treatment, Costs, Visas & Hospitals
ChinaCureLinkMay 258 min readBlogMedical Tourism from UAE to China: Costs, Treatments, Hospitals and Patient Journey
ChinaCureLinkMay 185 min readBlogDiabetes Stem Cell Treatment Cost in China (2026): What International Patients Should Know
ChinaCureLinkMay 155 min readBlogStem Cell Diabetes Treatment in China: A Step-by-Step Patient Guide : Explore stem cell diabetes treatment in China — types, eligibility, step-by-step process
ChinaCureLinkMay 156 min readBlogHow to Get CAR-T in China: A Step-by-Step Access Guide for International Patients (2026)
ChinaCureLinkApr 232 min readNewsMedebound HEALTH Signed Agreement with the PingAn Health Diagnostic Center Affiliated with PingAn Group